Hi @hammad and welcome to Mayo Clinic Connect. I'd also like to bring @allis9560 and @bearly into this discussion.

Hammad, just last year (March 2019) the U.S. Food and Drug Administration (FDA) granted accelerated approval to the first immunotherapy treatment for triple-negative breast cancer breast cancer. It combines the drug atezolizumab (Tecentriq) with a form of chemotherapy. You can read more about the treatment here:

– FDA Approves First Immunotherapy Drug for Triple-Negative Breast Cancer https://www.healthline.com/health-news/fda-approves-first-immunotherapy-drug-for-triple-negative-breast-cancer

Has this been discussed with you as a treatment option?

Hi doctor
Thanks I got the reply and studied all the details please check I also attched Cad Scan for review
Please advise in this case can we apply immunotherapy . And for how long we have to use this drug in this

Hi @hammad, I am not a doctor. If you would like to seek a medical opinion, please contact Mayo Clinic http://mayocl.in/1mtmR63

@colleenyoung @hammad
I came across a fascinating article today from the prestigious international journal NJP Nature Precision Oncology which revealed that an extract of honeybee venon apparently induces cancer cell death in hard to treat triple-negative and HER2-enriched breast cancer with minimal effect on healthy cells.
https://www.perkins.org.au/honeybee-venom-kills-breast-cancer-cells/

Very interesting…..I’m 5 yrs out now TNBC and BRCA 2 gene….

This is amazing! I am 1 week into treatment for TNBC and this is the first really positive alternative med story I have seen. Makes me feel a little more hopeful!

Congrats to you! Do you mind sharing your staging and treatment? I’m one week into treatment for TNBC and am really interested in hearing others stories.

@elizm, interesting and hopeful article for women with hard to treat triple negative breast cancer. It was completely clear in the article, but it sounds like the study is still in the early pre-human trial phase. Let's hope that the safety and efficacy studies on humans continue with positive results.

@syska, beautiful picture. Would you like to add it to your profile?
Here's how:
– How to Update Your Profile https://connect.mayoclinic.org/page/about-connect/newsfeed-post/how-to-update-your-profile/

I will reply and fix my info and pic but first need to do some healing and resting. Just had a Kock pouch redone with a couple complications… just got home.
Thanks now

Have any of you heard of a supplement called Vascu Statin that inhibits cancer recurrence?

VascuStatin Formula is convolvulis arvensis extract (common name, field bindweed). Memorial Sloan Kettering Cancer Center has great information about supplements, the evidence and risks of supplements and their relevance for cancer patients. (Thank you @clpc for bringing this to my attention.)

Here is the great information from MSKCC on convolvulis arvensis. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/convolvulis-arvensis

"Leaf extract of Convolvulis arvensis, also known as field bindweed, may stop the growth of new blood vessels. However, research is very limited and it has not been studied in humans.

Field bindweed is an invasive weed found in many parts of the world. It has been used in traditional medicine, and extracts from the leaves are sold as dietary supplements.

Lab studies suggest that these extracts may stimulate the immune system and stop the growth of new blood vessels. A few animal studies suggest it may also reduce tumor size in mice. However clinical trials have not been conducted, so whether this effect could occur in humans is not known. In addition, there could be adverse effects. For instance, because these extracts may affect the growth of new blood vessels, they may also interfere with wound healing."